Fritextsökning
Innehållstyper
-
Anna Törner: “My quantified life”
“The expression ‘you can’t see the forest for the trees’ feels newly relevant in the context of wearables. One can easily get caught up in the idea that the mor...
-
Anna Törner: Yes, I Am Sick, But Not Weak
”People often say that someone who is ill only has one wish—to get better. But I think that is not true. Someone who is ill also longs to be understood, to be r...
-
Vaccinbolag backade när Trump nominerade vaccinskeptiker
Flera av de stora vaccinbolagen föll på börsen efter att vaccinskeptikern Robert F. Kennedy Jr. på torsdagen nominerats till posten som hälsominister i Donald T...
-
Recipharm divests five Swedish plants
Swedish contract manufacturer Recipharm is selling its facilities in Solna, Strängnäs, Höganäs, Karlskoga and Uppsala OTC Development to US private equity compa...
-
Drug delivery-bolag till börsen
Nanexa genomför nyemission inför börsnotering.
-
Klarias migränstudie får grönt ljus
Ska starta upp en bioekvivalensstudie i Storbritannien.
-
Thumbs down for lecanemab in the EU – “Very surprised”
The Azheimer's drug lecanemab has received a negative assessment from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), acc...
-
Nanexa får utökat USA-patent
Nanexa får bredare skydd för drug delivery-plattformen Pharmashell.
-
”The importance of stratification in a statistician’s August kitchen”
Ingrid Lönnstedt writes about an experiment of her own at home and about what lessons can be learned from it, in a science column.
-
The fast route to a safe insulin pen
Diabetes is on the rise worldwide with around ten million people developing the disease every year. Demand for insulin pens allowing patients to self-medicate i...
-
From powder to implant
Quality assurance for additively manufactured implants.
-
Advancing 3D Culture Imaging: Insights from Academia, Biotech, and Pharma
Webinar | March 13, 2024, 12 PM EST.
-
Xbrane enters licensing agreement with Indian generics giant
Swedish biosimilar developer Xbrane Biopharma and the Indian company Intas Pharmaceuticals have entered into a license and co-development agreement.
-
Ny chef på Nanexa
Björn Svanström är företagets nya finanschef.
-
Efficient use of blood plasma
Blood plasma is an indispensable resource in the production of life-saving medicines. It is in high demand on global markets. To make more efficient use of this...
-
The Covid pandemic accelerated the development of cancer vaccine
The Covid pandemic gave a major boost to the vaccine field. The Danish biotech company Expres2ion Biotechnologies, which is developing a vaccine against breast ...
-
Framåt för Lidds drug delivery-teknik
Får nya patent för sin administreringsteknik och utvecklar ny läkemedelskandidat.
-
Revealing the secrets of a part
CT inspection in automation technology at Festo.
-
Anna Törner: ”Mom, do you think you’ll ever get married again?”
”I realize I’m slowly descending into that familiar statistical rabbit hole, where life’s biggest uncertainties are reduced to point estimates and confidence in...
-
The investor: “The major common diseases are hot again”
She has previously been voted Investor of the Year and will now be moderating The Future of Swedish & Danish Life Science congress. We check the temperature of ...
-
Ny vd på Klaria
Kommer närmast från Oberland Capital.
-
A new special edition and a new event in Copenhagen – This is happening at Life Science Sweden 2024
The new year brings new features for the readers of Life Science Sweden.
-
How to transport hydrogen - the BionicHydrogenBattery
Have you ever wondered how hydrogen should be transported and stored safely. Well, here is a solution for all who is interested in making a true infrastructure work.
-
“Everyone is screaming for talent”
Attracting talent is one of the life science industry’s major future challenges, which was one of the conclusions of the panel discussion that ended the New Hor...
BREAKING